PDPascal Djiadeu

Pascal Djiadeu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pascal Djiadeu has a total of 197 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Psychometric Evaluation of the HIV Knowledge Questionnaire-18 in a Black Canadian Population

    by Agatha Nyambi, Elizabeth Alvarez, Laura Anderson, Fatimah Jackson-Best, Wangari Tharao, Egbe Etowa, Shamara Baidoobonso, Maureen Owino, Pascal Djiadeu, Daeria Lawson, et al.

    This cross‑sectional study examined HIV/AIDS knowledge as a determinant of preventative and self‑protective sexual behaviour. The HIV Knowledge Questionnaire-18 (HIV-KQ-18) is one of the most widely used HIV knowledge scales. The objective of this study was to test the psychometric properties of the HIV-KQ-18 in Black people in Ontario. We analyzed the data from 1302 participants who completed the HIV-KQ-18 in a study conducted among Black people in Ontario. We estimated the internal consistency of this scale using Cronbach’s alpha. We analyzed the construct validity of the scale, testing hypotheses about HIV knowledge and age, education, employment status, gender, language and city using one-way ANOVA and independent sample t-tests. Cronbach’s alpha for the scale was 0.82 (95% CI: 0.80–0.84) suggesting good internal consistency. We observed significant differences in HIV knowledge scores across age, employment status, education, and gender. Higher HIV knowledge scores were also observed among participants residing in Toronto compared to Ottawa and among those who completed the questionnaire in English compared to French. The HIV-KQ-18 is a valid instrument to assess the level of HIV/AIDS knowledge among Black Ontarians, with robust internal consistency and construct validity. The HIV-KQ-18 identified important differences in HIV knowledge based on the characteristics examined, indicating the need for targeted initiatives to increase HIV-related knowledge.


  • Automated perfusion imaging did not improve reliability of ASPECTS or collateral score in late-window large vessel occlusion stroke

    by Anass Benomar, Robert Fahed, Abdelsimar Tan Omar, Christine Hawkes, Eef J Hendriks, Clare A Enriquez, Muneer Eesa, Grant Stotts, Hubert Lee, Shashank Nagendra, et al.

    Background: The Alberta Stroke Program Early CT Score (ASPECTS) and CT angiography (CTA) Collateral Score (CS) are routinely used to estimate ischemic core burden and collateral status in acute ischemic stroke due to large vessel occlusion, but suffer from limited reliability. Whether automated CT perfusion (CTP) maps improve scoring consistency remains unclear. Objectives: To assess the reliability of these scores on non-contrast computed tomography (NCCT) and CTA among numerous raters, with and without access to automated perfusion maps, and their correlations with endovascular thrombectomy (EVT) decisions. Methods: Twenty-nine clinicians independently rated 60 imaging cases from 30 late-window stroke patients with large vessel occlusion, each presented twice: once using NCCT and CTA alone (‘non-CTP cases’), and once with the addition of perfusion maps (‘CTP cases’). Twenty-eight raters (97%) completed the survey twice. Inter- and intra-reliability was assessed using Gwet’s AC1/2 coefficients (κ G ). Correlations with EVT decisions were evaluated using Cramer V. Results: Inter-rater reliability for ASPECTS was substantial and similar between non-CTP (κ G = 0.65, 95% CI: 0.53 to 0.78) and CTP cases (κ G = 0.64, 95% CI: 0.51 to 0.77). CS showed an almost perfect reliability in both scenarios (κ G = 0.82 and 0.83). Intra-rater agreement was at least substantial. Dichotomizing ASPECTS as 0-2/3-10 improved reliability to almost perfect. ASPECTS strongly correlated with EVT decisions (V=0.80), whereas CS showed moderate correlation (V=0.56), both remaining similar with the addition of CTP (V=0.75 and 0.54, respectively). Conclusion: Automated perfusion imaging did not improve the reliability of ASPECTS or CS. Strong reliability was achieved with NCCT and CTA alone.

  • Open Access

    The Association Between Different Levels of Suppressed Viral Load and the Risk of Sexual Transmission of HIV Among Serodiscordant Couples on Antiretroviral Therapy: A Systematic Review

    by Pascal Djiadeu, Housne Begum, Michelle Haavaldsrud, Giovanna Busa, Jeffery Dansoh, Phu Van Nguyen, Taline Ekmekjian, Annie Fleurant, Stephan Gadient, Chris Archibald

    The risk of sexual transmission of HIV in serodiscordant couples when the partner living with HIV (PLHIV) uses antiretroviral therapy (ART) and maintains a suppressed viral load (VL) (< 200 copies/mL) is estimated at 0.00 transmissions per 100 person-years (95% CI 0.00–0.10). A recent review reported an almost zero transmission risk for VL < 1000 copies/mL but lacked quantitative risk estimates. This systematic review aimed to quantify transmission risk across VL levels. A literature search (November 2023, updated January 2025) identified 152 studies, with 9 included in the analysis. Seven possible transmissions occurred when the PLHIV had a VL of < 1000 copies/mL at the last measurement before the estimated time of transmission. However, VL at the exact time of transmission was unknown and VL > 1000 copies/mL cannot be excluded. This review suggests sexual transmission is very rare with recent VL < 1000 copies/mL however, future research is required to establish precise risk estimates. PROSPERO Number: CRD42023476946.

  • Open Access

    Advancing HIV pre-exposure prophylaxis (PrEP) implementation in Canada: a scoping review protocol of programmes, practices and policies

    by Debapriya Chakraborty, Pascal Djiadeu, Carolyn Ziegler, Amani Chabikuli, Ezinne Ifeanacho, Moyo Awoliyi, Hannah Zuta, Graziella Djuidje De Pandja, Olaoluwa Ajiboye, Opeoluwa Ajiboye, et al.

    Introduction HIV pre-exposure prophylaxis (PrEP) is an effective HIV prevention tool, reducing infection risk by up to 99% when used as prescribed. Despite its proven efficacy, PrEP uptake remains suboptimal, particularly among high-risk populations in Canada. Barriers to access and uptake, including stigma, financial constraints and healthcare accessibility, persist, highlighting the need for targeted interventions. The objective of this scoping review is to identify and map the extent and types of interventions, programmes, practices and policies aimed at increasing the acceptance, access, uptake and sustained use of HIV PrEP in Canada. Methods and analysis This review will use the Joanna Briggs Institute (JBI) Scoping Review methodology. Databases to be searched are MEDLINE, Embase, PsycINFO, Cochrane Library, CINAHL, Scopus and Web of Science from 2016 onwards. Two independent reviewers will screen studies, based on the inclusion criteria. The search results will be presented in a Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. Data will be extracted from relevant studies by two independent reviewers and summarised to inform future research and policy development. This review will include studies focusing on individuals in Canada who are eligible for or using PrEP for HIV prevention. The interventions considered will address the awareness, acceptance, access, uptake and sustained use of PrEP. Studies must be set within the Canadian context, considering geographic, cultural and systemic factors. Exclusions include studies conducted outside Canada or those not addressing HIV prevention interventions. Ethics and dissemination This research will rely exclusively on previously published data and will not include human participants. Therefore, ethics approval is not required. For further clarification, please contact Stephen Hwang, Director, MAP Centre for Urban Health Solutions, Unity Health Toronto, at Stephen.Hwang@unityhealth.to. The findings of this research will be shared through peer-reviewed journal articles, conference presentations and may be relevant to governmental health agencies and local HIV/AIDS service organisations. Registration The protocol has been registered with Open Science Framework at https://doi.org/10.17605/OSF.IO/C7S4Z.


  • Open Access

    Barriers and facilitators of HIV pre-exposure prophylaxis (PrEP) uptake and use in Canada: a scoping review protocol

    by Amani Chabikuli, Debapriya Chakraborty, Carolyn Ziegler, Pascal Djiadeu, Kelly Mgbatogu, Ezinne Ifeanacho, Olaoluwa Ajiboye, Jason Lo Hog Tian, Judith Odhiambo, LaRon E Nelson, et al.

    Introduction Despite extensive efforts in HIV prevention, significant barriers to accessing interventions such as HIV pre-exposure prophylaxis (PrEP) persist in Canada. Although PrEP has demonstrated efficacy in preventing HIV transmission, various structural, social and systemic factors continue to impede its widespread adoption and use. These factors influence the uptake (acceptance and access) and use (adherence and retention) of PrEP. The purpose of this scoping review is to examine the existing body of evidence regarding the barriers and facilitators to uptake and use of PrEP in Canada. By identifying these factors, the review aims to inform future research, policy development and interventions to improve PrEP access and its integration into HIV prevention strategies in Canada. Methods and analysis This scoping review will focus on studies involving HIV-seronegative individuals in Canada who are either eligible for or currently using PrEP as an HIV prevention option. The review will consider barriers and facilitators within services, programmes, policies or practices related to HIV prevention in Canada. Eligible studies will include experimental, quasi-experimental, observational or qualitative designs. Studies that do not address PrEP or HIV prevention, or that involve populations not aligned with the inclusion criteria, will be excluded. The review will involve searching a range of key databases, including MEDLINE, Embase, PsycINFO, Cochrane Library, CINAHL, Scopus, Web of Science and TRIP, with no language restrictions, and focusing on publications from 2016 onward. Two independent reviewers will screen titles and abstracts, followed by full-text assessment and data extraction, using Covidence. Data will be analysed narratively, with a specific focus on subgroup analyses of key populations. The findings will be synthesised to provide an overview of the key themes, trends, and evidence gaps identified within the existing literature. Ethics and dissemination This piece of research will not involve human participants and will solely use already published data. Consequently, ethics approval is not necessary. The findings will be disseminated through peer-reviewed journal articles and conference presentations and may be of relevance to governmental health agencies and local HIV/AIDS service organisations. Trial registration The protocol has been registered on Open Science Framework registries at https://doi.org/10.17605/OSF.IO/69WJA.

  • Open Access

    Developing a reporting item checklist for studies of HIV drug resistance prevalence or incidence: a mixed methods study

    by Cristian Garcia, Anne Holbrook, Pascal Djiadeu, Elizabeth Alvarez, Jéssyca Matos Silva, Lawrence Mbuagbaw

    Background Adequate surveillance of HIV drug resistance prevalence is challenged by heterogenous and inadequate data reporting. To address this issue, we recently published reporting guidance documentation for studies of HIV drug resistance prevalence and incidence. Objectives In this study, we describe the methods used to develop this reporting guidance. Design We used a mixed-methods sequential explanatory design involving authors and users of studies of HIV drug resistance prevalence. In the quantitative phase, we conducted a cross-sectional electronic survey (n=51). Survey participants rated various reporting items on whether they are essential to report. Validity ratios were computed to determine the items to discuss in the qualitative phase. In the qualitative phase, two focus group discussions (n=9 in total) discussed this draft item checklist, providing a justification and examples for each item. We conducted a descriptive qualitative analysis of the group discussions to identify emergent themes regarding the qualities of an essential reporting item. Results We identified 38 potential reporting items that better characterise the study participants, improve the interpretability of study results and clarify the methods used for HIV resistance testing. These items were synthesised to create the reporting item checklist. Qualitative insights formed the basis of the explanation, elaboration, and rationale components of the guidance document. Conclusions We generated a list of reporting items for studies on the incidence or prevalence of HIV drug resistance along with an explanation of why researchers believe these items are important. Mixed methods allowed for the simultaneous generation and integration of the item list and qualitative insights. The integrated findings were then further developed to become the subsequently published reporting guidance.


  • Top Cited Papers
    Open Access

    Scoping review of HIV-related intersectional stigma among sexual and gender minorities in sub-Saharan Africa

    by Debbie Dada, Gamji R Abu-Ba’are, DeAnne Turner, Ibrahim Wunpini Mashoud, Francis Owusu-Dampare, Amos Apreku, Zhao Ni, Pascal Djiadeu, Gloria Aidoo-Frimpong, Edem Yaw Zigah, et al.

    Objectives: Sexual and gender minority (SGM) populations in sub-Saharan Africa (SSA) are disproportionately impacted by HIV and often face multiple HIV-related stigmas. Addressing these stigmas could reduce SGM HIV vulnerability but little is known about how the stigmas operate and intersect. Intersectional stigma offers a lens for understanding the experiences of stigmatised populations and refers to the synergistic negative health effects of various systems of oppression on individuals with multiple stigmatised identities, behaviours or conditions. This review aims to (1) assess how often and in what ways an intersectional lens is applied in HIV-related stigma research on SGM populations in SSA and (2) understand how intersectional stigma impacts HIV risk in these populations.Design: Scoping review following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews.Data sources: Public health and regional databases were searched in 2020 and 2022.Eligibility criteria: Articles in French and English on HIV-related stigma and HIV outcomes among men who have sex with men, women who have sex with women and/or transgender individuals in SSA.Data extraction and synthesis: Articles were screened and extracted twice and categorised by use of an intersectional approach. Study designs and stigma types were described quantitatively and findings on intersectional stigma were thematically analysed.Results: Of 173 articles on HIV-related stigma among SGM in SSA included in this review, 21 articles (12%) applied an intersectional lens. The most common intersectional stigmas investigated were HIV and same-sex attraction/behaviour stigma and HIV, same-sex attraction/behaviour and gender non-conformity stigma. Intersectional stigma drivers, facilitators and manifestations were identified across individual, interpersonal, institutional and societal socioecological levels. Intersectional stigma impacts HIV vulnerability by reducing HIV prevention and treatment service uptake, worsening mental health and increasing exposure to HIV risk factors.Conclusion: Intersectional approaches are gaining traction in stigma research among SGM in SSA. Future research should prioritise quantitative and mixed methods investigations, diverse populations and intervention evaluation.


  • Open Access

    HIV Prevention and Treatment Interventions for Black Men Who Have Sex With Men in Canada: Scoping Systematic Review

    by Jemal Demeke, Pascal Djiadeu, Abban Yusuf, Darren Lovell Whitfield, David Lightfoot, Fiqir Worku, Gamji Rabiu Abu-Ba'ARe, Lawrence Mbuagbaw, Sulaimon Giwa, LaRon E Nelson

    Background: Black men who have sex with men (MSM) experience disproportionately high HIV incidence globally. A comprehensive, intersectional approach (race, gender, and sexuality or sexual behavior) in understanding the experiences of Black MSM in Canada along the HIV prevention and care continuums has yet to be explored. Objective: This scoping review aims to examine the available evidence on the access, quality, gaps, facilitators, and barriers of engagement and identify interventions relevant to the HIV prevention and care continuum for Black MSM in Canada. Methods: We conducted a systematic database search, in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) checklist, of the available studies on HIV health experience and epidemiology concerning Black MSM living with or without HIV in Canada and were published after 1983 in either English or French. Searched databases include MEDLINE, Excerpta, Cumulative Index to Nursing and Allied Health Literature, the Cochrane Library, the NHUS Economic Development Database, Global Health, PsycInfo, PubMed, Scopus, and Web of Science. From the 3095 articles identified, 19 met the inclusion criteria and were analyzed. Results: Black MSM in Canada consistently report multiple forms of stigma and lack of community support contributing to an increased HIV burden. They experience discrimination based on their intersectional identities while accessing HIV preventative and treatment interventions. Available data demonstrate that Black MSM have higher HIV incidences than Black men who have sex with women (MSW) and White MSM, and low preexposure prophylaxis knowledge and HIV literacy. Black MSM experience significant disparities in HIV prevention and care knowledge, access, and use. Structural barriers, including anti-Black racism, homophobia, and xenophobia, are responsible for gaps in HIV prevention and care continuums, poor quality of care and linkage to HIV services, as well as a higher incidence of HIV. Conclusions: Considering the lack of targeted interventions, there is a clear need for interventions that reduce HIV diagnoses among Black MSM, increase access and reduce structural barriers that significantly affect the ability of Black MSM to engage with HIV prevention and care, and address provider’s capacity for care and the structural barriers. These findings can inform future interventions, programming, and tools that may alleviate this HIV inequity. International Registered Report Identifier (IRRID): RR2-10.1136/bmjopen-2020-043055


  • Open Access

    Risque de transmission sexuelle du VIH dans le contexte de la suppression de la charge virale

    by Pascal Djiadeu, Housne Begum, Stacy Sabourin, Stephan Gadient, Chris Archibald, Marc-André LeBlanc, Andrea Chittle, Annie Fleurant, Joseph Cox

  • Open Access

    Clinical Uncertainty In Large Vessel Occlusion Ischemic Stroke (CULVO): An Intrarater And Interrater Agreement Study

    by Jose Danilo B. Diestro, Robert Fahed, Abdelsimar T. Omar, Christine Hawkes, Eef J. Hendriks, Clare Angeli Enriquez, Muneer Eesa, Grant Stotts, Hubert Lee, Shashank Nagendra, et al.

    Background: Limited research exists regarding the impact of neuroimaging modality on endovascular thrombectomy (EVT) decisions for late window large vessel occlusion (LVO) stroke cases. Purpose: This study assesses whether perfusion CT imaging: 1) alters the proportion of recommendations for EVT, and 2) enhances the reliability of EVT decision-making compared to non-contrast CT and CT angiography. Materials and Methods: We conducted an online survey using 30 patients drawn from an institutional database of 3144 acute stroke cranial CT scans. These cases were presented to 29 stroke or neurointerventional physicians from Canada across two sessions. Physicians evaluated each patient both with and without perfusion imaging and gave EVT recommendations. We used non-overlapping 95% confidence intervals and difference in agreement classification as criteria to suggest a difference between the Gwet AC1 statistics (κ G ). Our outcomes were: 1) the proportion of EVT recommendations, and 2) interrater and intrarater agreement, with or without perfusion imaging. Results: In the first round, 29 raters completed the assessment, with 28 finishing the second round. The percentage of EVT recommendations differed by 1.1% with or without perfusion imaging. However, individual decisions changed in 21.4% of cases, with 11.3% against EVT and 10.1% in favor. Interrater agreement (κG) among the 29 raters was similar between non-perfusion CT neuroimaging and perfusion CT neuroimaging (κG = 0.487; 95% CI 0.327, 0.647 and κG = 0.552; 95% CI 0.430, 0.675). The 95% CIs overlapped with moderate agreement in both. Intrarater agreement exhibited overlapping 95% CIs for all 28 raters. κG was either substantial or excellent (0.81-1) for 71.4% (20/28) of raters in both groups. Conclusion: The difference in EVT recommendations is minimal with either neuroimaing protocol. Regarding agreement we found that use of automated CT perfusion images does not significantly impact the reliability of EVT decisions for late window LVO patients.